The Duke Cancer Institute (DCI) wants to assure our patients that the safety of our patients, their loved ones, our team members and the community at large remains our highest priority. We are closely monitoring this rapidly evolving situation and are implementing all necessary precautions to prevent the spread of infection.

For the latest information about how we are keeping our community safe, please visit www.dukehealth.org.

BRCA2

Hereditary Prostate Cancer Linked to Family History of Breast, Ovarian Cancer

If mothers, sisters and daughters have a history of breast and ovarian cancers, a man's risk for prostate cancer is also significantly increased.

March 24, 2020

DCI Research

Risk-Reducing Surgery Questioned For Some BRCA Mutation Carriers

Mutations in the BRCA gene correspond to a higher lifetime risk of developing breast and ovarian cancers, and many women who carry these mutations con...

July 11, 2017

Announcements DCI Research

Women with BRCA1 Gene Mutation at Higher Risk of Deadly Uterine Cancer

Women who carry the BRCA1 gene mutation that dramatically increases their risk of breast and ovarian cancers are also at higher risk for a lethal form...

June 30, 2016

Announcements DCI Research